T4K3.news
Serena Williams sheds 31 pounds with GLP-1 therapy
Serena Williams says GLP-1 treatment helped her reach a healthier weight after two pregnancies, sparking discussion about openness and stigma.
The tennis legend discusses using GLP-1 medication from Ro to reach a healthier weight after two pregnancies.
Serena Williams sheds 31 pounds with GLP-1 therapy
Serena Williams revealed on Today that she has used GLP-1 medications from Ro to support weight loss after having two children. She said she has lost 31 pounds in eight months and noted she had tried many traditional methods before turning to the treatment. Williams is open about her decision, describing the process as a personal health choice rather than a shortcut.
GLP-1 drugs work by mimicking a hormone that helps regulate blood sugar, slow digestion, and increase fullness, according to Ro’s descriptions. Williams stressed that she wanted to break the stigma around weight loss medications and to encourage a candid conversation about health and body image, especially for women who have recently become mothers. She also reflected on her long relationship with tennis and how the end of full-time competition reshaped her perspective on health and performance.
Key Takeaways
"I literally tried everything. Running, walking, biking, stairclimber, you name it, I did it."
Williams describes her exhaustive efforts before turning to GLP-1 therapy.
"But it actually isn’t and there’s something that I feel personally that my body was missing after having two kids, I wasn’t able to be at a weight that was healthy for me."
Reason she pursued GLP-1 treatment.
"There’s no need to just not deny it, it is what it is and I love how I’m feeling now."
Advocating openness about GLP-1 use.
"I saw my friends using it, I saw a lot of people on it and I tried it and it actually worked."
She explains how the decision came about.
The interview places the weight management debate in the sphere of celebrity influence, brand sponsorships, and public accountability. Williams’s profile amplifies both curiosity and skepticism about GLP-1 therapies in athletes. The piece hints at broader tensions between medical treatment, personal choice, and the pressure athletes face to manage body image under scrutiny.
Beyond sport, the disclosure could shape conversations about openness in health decisions, especially for high-profile figures who navigate sponsorship deals and public expectations. The focus shifts from individual bodies to the social dynamics around weight, health, and accountability in professional arenas.
Highlights
- Health is a journey, not a shortcut
- Honesty beats gossip about weight
- Open talk changes the game more than silence
- Strength shows up in many forms not just on court
Sensitive topic risk GLP-1 use by a high-profile athlete
The article touches on health treatment choices by a famous sport figure and intersects with sponsorships and public opinion, raising potential backlash and political considerations about medical privacy and industry influence.
The health journey of public figures often fuels wider debates about responsibility and honesty.
Enjoyed this? Let your friends know!
Related News
Serena Williams reveals GLP-1 weight loss
Serena Williams GLP-1 endorsement under scrutiny
Serena Williams opens up about GLP-1 use
Serena Williams weighs in on weight loss drugs and stigma
RA patient defies denial with GLP-1 treatment
GLP-1 use for arthritis sparks access questions
GLP-1 drugs show potential for PCOS treatment
Weight loss with GLP-1 drugs changes life
